|
| Theoretical analysis of Jinhua Qinggan Granules in the treatment of Corona Virus Disease 2019 |
| Hits 133 Download times 42 Received:April 20, 2024 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2024.09.01 |
| Key Words
Jinhua Qinggan Granule;Corona Virus Disease 2019;fuzao;anemarrhena asphodeloides |
| Author Name | Affiliation | E-mail | | SHI Naixin | Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | | | WU Shengxian | Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China | wushx@sina.com |
|
| Abstract
|
| Jinhua Qinggan Granule was developed in the epidemic period of influenza(H1N1),and its formulation is mainly composed of the classic prescription yinqiao powder and Maxing Shigantang Decoction. The pathogenesis is the internal dryness and wind heat attack the lungs,and anemarrhena asphodeloides is the punchline of the formulation,which plays the effect of strengthening yin and guarding wei. Jinhua Qinggan Granules have shown high clinical efficacy in the prevention and treatment of Corona Virus Disease 2019(COVID-19). In the prevention and treatment of mild cases of COVID-19,the main syndrometypes targeted by Jinhua Qinggan Granules are:dry latent taiyin,dry and wet,and wei qi co-morbidity,which further emphasizes the importance of the pathogenesis of dry and latent in the pathogenesis of influenza and provides a new idea for the prevention and treatment of influenza in the future. |
|
|
|
|
|
